Cancer care cost trends in the United States: 1998 to 2012. (Q40101403)

17 September 2017

title

Cancer care cost trends in the United States: 1998 to 2012. (English)

1 reference

17 September 2017

James A Lee

1

1 reference

17 September 2017

Charles S Roehrig

series ordinal

2

1 reference

17 September 2017

Erin Duggan Butto

series ordinal

3

1 reference

17 September 2017

language of work or name

English

0 references

publication date

15 January 2016

1 reference

17 September 2017

1 reference

17 September 2017

volume

122

1 reference

17 September 2017

issue

7

1 reference

17 September 2017

page(s)

1078-1084

1 reference

Cancer treatment and survivorship statistics, 2014

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Projections of the cost of cancer care in the United States: 2010-2020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Evaluation of trends in the cost of initial cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Delivering high-quality and affordable care throughout the cancer care continuum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Five myths about cancer care in America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Association of insurance with cancer care utilization and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Elimination of cost-sharing and receipt of screening for colorectal and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

American Society of Clinical Oncology guidance statement: the cost of cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Impact of the cost of cancer treatment: an internet-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

National health spending by medical condition, 1996-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Reconciling medical expenditure estimates from the MEPS and NHEA, 2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

Cancer treatment cost in the United States: has the burden shifted over time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

inferred from DOI database lookup

7 January 2021

based on heuristic

Limits on Medicare's ability to control rising spending on cancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

inferred from DOI database lookup

7 January 2021

based on heuristic

Ensuring Patient Access to Affordable Cancer Drugs: Workshop Summary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29883

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.29883

1 reference

17 September 2017

1 reference